Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02223598 |
| Title | A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies (CLC-102) |
| Acronym | CLC-102 |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Cleave Biosciences, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010 | United States | Details | |
| University of California, San Francisco | San Francisco | California | 94143 | United States | Details | |
| Emory University | Atlanta | Georgia | 30322 | United States | Details | |
| RCCA MD | Bethesda | Maryland | 20817 | United States | Details | |
| Washington University | Saint Louis | Missouri | 63110 | United States | Details | |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | United States | Details | |
| Princess Margaret Cancer Centre | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Cedars Cancer Centre, McGill University Health Centre | Montreal | Quebec | H4A 3J1 | Canada | Details |